Breast Cancer/Risk

Hormone Replacement Therapy Not Linked to Increased Risk

Published in Cancer Weekly, July 24th, 1995

Middle-aged women who take estrogen or a combination of estrogen and progestin as hormone replacement therapy (HRT) apparently do not face an increased risk for breast cancer, according to an article in the July 11, 1995, issue of the Journal of the American Medical Association.

Janet L. Stanford, Ph.D., with the Division of Public Health Sciences at the Fred Hutchinson Cancer Research Center and associate professor of epidemiology at the University of Washington, Seattle, and colleagues, studied the medical histories of 1,029 women in northwestern Washington state. The women were 50-64 years of age. More than half (537) had been diagnosed with breast cancer and were...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-07-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry